Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 16.39%
This Quarter Est. Return
1 Year Est. Return
+16.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
+$16.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,187
New
Increased
Reduced
Closed

Top Buys

1 +$342M
2 +$80.6M
3 +$71.2M
4
CG icon
Carlyle Group
CG
+$69.9M
5
SPY icon
SPDR S&P 500 ETF Trust
SPY
+$67.8M

Top Sells

1 +$1.17B
2 +$628M
3 +$483M
4
MSFT icon
Microsoft
MSFT
+$272M
5
AEE icon
Ameren
AEE
+$67.1M

Sector Composition

1 Financials 16.85%
2 Consumer Discretionary 14.15%
3 Technology 13.17%
4 Industrials 10.88%
5 Consumer Staples 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMEA icon
3051
Biomea Fusion
BMEA
$108M
-14,117
BSAC icon
3052
Banco Santander Chile
BSAC
$14.2B
-14,384
BTG icon
3053
B2Gold
BTG
$6.25B
-2,000,000
BTMD icon
3054
Biote Corp
BTMD
$84.1M
-33,180
BUD icon
3055
AB InBev
BUD
$121B
-225,113
BVN icon
3056
Compañía de Minas Buenaventura
BVN
$6.84B
-42,184
CATX icon
3057
Perspective Therapeutics
CATX
$190M
-115,255
CATY icon
3058
Cathay General Bancorp
CATY
$3.46B
-13,514
CBT icon
3059
Cabot Corp
CBT
$3.61B
-6,351
CBU icon
3060
Community Bank
CBU
$3.18B
-13,094
CCRN icon
3061
Cross Country Healthcare
CCRN
$268M
-35,910
CGAU
3062
Centerra Gold
CGAU
$2.8B
-55,315
CGNT icon
3063
Cognyte Software
CGNT
$701M
-33,784
CGON icon
3064
CG Oncology
CGON
$3.37B
-44,051
CKPT
3065
DELISTED
Checkpoint Therapeutics
CKPT
-150,000
CMPX icon
3066
Compass Therapeutics
CMPX
$939M
-32,245
CNA icon
3067
CNA Financial
CNA
$12.1B
-11,047
CNTA
3068
Centessa Pharmaceuticals
CNTA
$4.37B
-42,437
COKE icon
3069
Coca-Cola Consolidated
COKE
$10.8B
-1,530
CORT icon
3070
Corcept Therapeutics
CORT
$8.99B
-10,122
CPA icon
3071
Copa Holdings
CPA
$4.78B
-2,525
CRBP icon
3072
Corbus Pharmaceuticals
CRBP
$181M
-22,485
CRGX
3073
DELISTED
CARGO Therapeutics
CRGX
-91,405
CRNC icon
3074
Cerence
CRNC
$525M
-129,049
CRVS icon
3075
Corvus Pharmaceuticals
CRVS
$635M
-24,413